New England Research & Management Inc. reduced its holdings in UnitedHealth Group Inc (NYSE:UNH) by 13.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,300 shares of the healthcare conglomerate’s stock after selling 525 shares during the period. New England Research & Management Inc.’s holdings in UnitedHealth Group were worth $717,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Garrison Point Advisors LLC boosted its holdings in UnitedHealth Group by 1.2% during the second quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock worth $851,000 after buying an additional 40 shares in the last quarter. Clear Harbor Asset Management LLC boosted its holdings in UnitedHealth Group by 0.6% during the third quarter. Clear Harbor Asset Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock worth $1,428,000 after buying an additional 40 shares in the last quarter. Smith Moore & CO. boosted its holdings in UnitedHealth Group by 1.3% during the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock worth $770,000 after buying an additional 41 shares in the last quarter. Integrated Investment Consultants LLC boosted its holdings in UnitedHealth Group by 3.9% during the second quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 42 shares in the last quarter. Finally, Meridian Financial Partners LLC boosted its holdings in UnitedHealth Group by 2.7% during the second quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock worth $403,000 after buying an additional 43 shares in the last quarter. 85.66% of the stock is currently owned by institutional investors and hedge funds.

UNH has been the topic of a number of recent analyst reports. Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. UBS Group lowered their price target on shares of UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating on the stock in a report on Thursday, October 17th. Barclays set a $260.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, October 8th. Mizuho initiated coverage on shares of UnitedHealth Group in a report on Thursday, October 17th. They set a “buy” rating and a $270.00 price target on the stock. Finally, Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, October 15th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $283.84.

NYSE:UNH traded up $0.51 during trading hours on Friday, reaching $256.97. 2,200,215 shares of the company were exchanged, compared to its average volume of 4,544,972. The company has a current ratio of 0.70, a quick ratio of 0.67 and a debt-to-equity ratio of 0.67. The stock’s 50-day moving average is $234.76 and its 200-day moving average is $241.05. The firm has a market cap of $237.20 billion, a PE ratio of 19.95, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.75 by $0.13. The company had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $3.41 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Inc will post 14.96 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio is presently 33.54%.

In other news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the completion of the sale, the director now directly owns 187,979 shares in the company, valued at $43,874,298.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Timothy Patrick Flynn bought 2,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 28th. The stock was acquired at an average price of $227.55 per share, with a total value of $455,100.00. Following the completion of the transaction, the director now directly owns 5,524 shares of the company’s stock, valued at $1,256,986.20. The disclosure for this purchase can be found here. Insiders have sold 33,177 shares of company stock valued at $7,842,582 over the last 90 days. 0.87% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Google Finance Portfolio Workaround

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.